Hyperalgesia: An emerging iatrogenic syndrome

被引:80
作者
Mercadante, S
Ferrera, P
Villari, P
Arcuri, E
机构
[1] La Maddalena Canc Ctr, Pain Relief & Palliat Care Unit, Anesthesia & Intens Care Unit, I-90146 Palermo, Italy
[2] NCI, Pain Relief & Intens Care Unit, Rome, Italy
关键词
hyperalgesia; tolerance; cancer pain; opioids; spinal opioids; local anesthetics;
D O I
10.1016/S0885-3924(03)00258-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Clinical reports suggest that opioids, intended to abolish pain, can unexpectedly produce hyperalgesia. This paradoxical effect may be mechanistically related to tolerance induced by increasing doses of opioids. Two case reports illustrate a syndrome characterized by increasing pain pursued by escalating opioid doses, which results in a worsening of the clinical picture. Several experimental data may help explain the course of this challenging clinical condition. In escalating opioid doses rapidly, a risk of opioid-induced hyperalgesia should be recognized, as higher doses of opioids may stimulate rather than inhibit the central nervous system by different mechanisms. Alternative procedures should be taken into consideration to break this cycle, should it occur. More data are needed to detect this condition, as currently no diagnostic information on specific markers, clinical or biochemical, exists. (C) 2003 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:769 / 775
页数:7
相关论文
共 37 条
[1]   Dynorphin A increases substance P release from trigeminal primary afferent C-fibers [J].
Arcaya, JL ;
Cano, G ;
Gómez, G ;
Maixner, W ;
Suárez-Roca, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (01) :27-34
[2]  
Arcuri E, 1998, J PAIN SYMPTOM MANAG, V16, P78
[3]  
BOWSHER D, 1993, BRIT MED J, P306
[4]  
Cadet P, 2001, Med Sci Monit, V7, P1123
[5]   Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability [J].
Crain, SM ;
Shen, KF .
PAIN, 2000, 84 (2-3) :121-131
[6]   Opioid use in cancer pain. Is a more liberal approach enhancing toxicity? [J].
Daeninck, PJ ;
Bruera, E .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1999, 43 (09) :924-938
[7]   DIFFERENTIAL RIGHT SHIFTS IN THE DOSE-RESPONSE CURVE FOR INTRATHECAL MORPHINE AND SUFENTANIL AS A FUNCTION OF STIMULUS-INTENSITY [J].
DIRIG, DM ;
YAKSH, TL .
PAIN, 1995, 62 (03) :321-328
[8]   Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists [J].
Ebert, B ;
Thorkildsen, C ;
Andersen, S ;
Christrup, LL ;
Hjeds, H .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (05) :553-559
[9]   Preemptive hyperalgesia, not analgesia? [J].
Eisenach, JC .
ANESTHESIOLOGY, 2000, 92 (02) :308-309
[10]   IS THIS OPIOID ANALGESIC TOLERANCE [J].
FAINSINGER, RL ;
BRUERA, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (07) :573-577